Design, and baseline characteristics of the FIND-CKD trial: Efficacy of Finerenone on kidney disease progression in people with non[1]diabetic chronic kidney disease
Document Type
Abstract
Publication Date
8-1-2023
Keywords
washington; prmc; spokane
Abstract
Accepted for poster presentation at ASN Kidney Week 2023
Clinical Institute
Kidney & Diabetes
Department
Endocrinology
Department
Nephrology
Recommended Citation
Heerspink, HJL; Tuttle, Katherine; and See all authors in comments, "Design, and baseline characteristics of the FIND-CKD trial: Efficacy of Finerenone on kidney disease progression in people with non[1]diabetic chronic kidney disease" (2023). Articles, Abstracts, and Reports. 8240.
https://digitalcommons.providence.org/publications/8240
Comments
Heerspink HJL, Agarwal R, Bakris GL, Cherney DZI, Lam C, Neuen BL, Tuttle KR, Wanner C, Brinker MD, Dizayee S, Kolkhof P, Schloemer P, Vesterinen P, Perkovic V. Design, and baseline characteristics of the FIND-CKD trial: Efficacy of Finerenone on kidney disease progression in people with non[1]diabetic chronic kidney disease. Accepted for poster presentation at ASN Kidney Week 2023.